Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma

被引:16
|
作者
Xu, Ziwu [1 ,2 ]
Pei, Chaozhu [2 ]
Cheng, Haojie [2 ]
Song, Kaixin [1 ]
Yang, Junting [1 ]
Li, Yuhang [1 ]
He, Yue [1 ]
Liang, Wenxuan [1 ]
Liu, Biyuan [3 ]
Tan, Wen [4 ]
Li, Xia [5 ]
Pan, Xue [1 ]
Meng, Lei [1 ]
机构
[1] Hunan Univ Chinese Med, Sch Pharm, Changsha, Peoples R China
[2] Hunan Univ, Coll Biol, Changsha, Peoples R China
[3] Hunan Univ Chinese Med, Sch Med, Changsha, Peoples R China
[4] Changsha Hosp Tradit Chinese Med, Changsha Hosp 8, Dept Pathol, Changsha, Peoples R China
[5] Peoples Hosp Hunan Prov, Dept Gen Surg, Changsha, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
FoxM1; hepatocellular carcinoma; immune infiltration; m6A modification; glycolysis; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; CANCER; EXPRESSION; HALLMARKS; TARGETS; PLAYERS; ROLES;
D O I
10.3389/fimmu.2023.1138524
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundForkhead box M1 (FOXM1) is a member of the Forkhead box (Fox) transcription factor family. It regulates cell mitosis, cell proliferation, and genome stability. However, the relationship between the expression of FOXM1 and the levels of m6a modification, immune infiltration, glycolysis, and ketone body metabolism in HCC has yet to be fully elucidated. MethodsTranscriptome and somatic mutation profiles of HCC were downloaded from the TCGA database. Somatic mutations were analyzed by maftools R package and visualized in oncoplots. GO, KEGG and GSEA function enrichment was performed on FOXM1 co-expression using R. We used Cox regression and machine learning algorithms (CIBERSORT, LASSO, random forest, and SVM-RFE) to study the prognostic value of FOXM1 and immune infiltrating characteristic immune cells in HCC. The relationship between FOXM1 and m6A modification, glycolysis, and ketone body metabolism were analyzed by RNA-seq and CHIP-seq. The competing endogenous RNA (ceRNA) network construction relies on the multiMiR R package, ENCORI, and miRNET platforms. ResultsFOXM1 is highly expressed in HCC and is associated with a poorer prognosis. At the same time, the expression level of FOXM1 is significantly related to the T, N, and stage. Subsequently, based on the machine learning strategies, we found that the infiltration level of T follicular helper cells (Tfh) was a risk factor affecting the prognosis of HCC patients. The high infiltration of Tfh was significantly related to the poor overall survival rate of HCC. Besides, the CHIP-seq demonstrated that FOXM1 regulates m6a modification by binding to the promoter of IGF2BP3 and affects the glycolytic process by initiating the transcription of HK2 and PKM in HCC. A ceRNA network was successfully obtained, including FOXM1 - has-miR-125-5p - DANCR/MIR4435-2HG ceRNA network related to the prognosis of HCC. ConclusionOur study implicates that the aberrant infiltration of Tfh associated with FOXM1 is a crucial prognostic factor for HCC patients. FOXM1 regulates genes related to m6a modification and glycolysis at the transcriptional level. Furthermore, the specific ceRNA network can be used as a potential therapeutic target for HCC.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Characterization of m6A RNA methylation mediated immune heterogeneity and functional validation in hepatocellular carcinoma
    Zhang, Chongyou
    Huang, Yang
    Liang, Ming
    Wu, Jinrong
    Wang, Guangyou
    ENVIRONMENTAL TOXICOLOGY, 2024,
  • [42] Oncogenic role of SKA2 and its ceRNA network in hepatocellular carcinoma based on a comprehensive analysis
    Hu, Wanxue
    Hu, Xiaoyi
    Zhu, Yongchao
    Li, Min
    Meng, Hongyu
    Zhao, Hongbo
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (10) : 5190 - 5201
  • [43] Comprehensive Analysis of the PROSER2-AS1-Related ceRNA Network and Immune Cell Infiltration in Papillary Thyroid Carcinoma
    Wang, Tingting
    Yu, Qian
    Zhang, Wei
    Gao, Li
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 1647 - 1663
  • [44] N6-methyladenosine (m6A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1
    Tang, Bingxi
    Li, Mingdong
    Xu, Yanbing
    Li, Xinli
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5037 - 5045
  • [45] N6-methyladenosine (m6A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1
    Bingxi Tang
    Mingdong Li
    Yanbing Xu
    Xinli Li
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5037 - 5045
  • [46] Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
    Liu, Yue
    Fu, Bidong
    Yu, Zichuan
    Song, Gelin
    Zeng, Hong
    Gong, Yiyang
    Ding, Yongqi
    Huang, Da
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 497 - 516
  • [47] Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Hepatocellular Carcinoma With Vascular Invasion
    Cai, Shijiao
    Du, Renle
    Zhang, Yuan
    Yuan, Zhengyi
    Shang, Jie
    Yang, Yang
    Han, Bin
    Zhong, Weilong
    Yuan, Hengjie
    Li, Zhengxiang
    FRONTIERS IN BIOINFORMATICS, 2022, 2
  • [48] FOXM1 Expression Correlates with both in vivo and in vitro AFP production and Therapeutic Effect of Thiostrepton on Human Hepatocellular Carcinoma
    Feng, Huang S.
    Gang, Ai J.
    Yan, Wu
    Juan, Chen J.
    Zhang, Liping
    HEPATOLOGY, 2013, 58 : 1085A - 1085A
  • [49] Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis
    Liu, Zhixin
    Liu, Heng
    Li, Deqiang
    Ma, Liang
    Lu, Tongxin
    Sun, Hao
    Zhang, Yuankai
    Yang, Hui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Comprehensive analysis of m6A regulators characterized by the immune microenvironment in Duchenne muscular dystrophy
    Han, Xu
    Ji, Guang
    Wang, Ning
    Yi, Le
    Mao, Yafei
    Deng, Jinliang
    Wu, Hongran
    Ma, Shaojuan
    Han, Jingzhe
    Bu, Yi
    Fang, Pingping
    Liu, Juyi
    Sun, Fanzhe
    Song, Xueqin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)